Illumina beats by $0.07, beats on revs; guides FY14 EPS & revs higher
Reports Q2 (Jun) earnings of $0.57 per share, $0.07 better than the Capital IQ Consensus Estimate of $0.50; revenues rose 29.5% year/year to $448 mln vs the $425.75 mln consensus.
Co issues upside guidance for FY14, sees EPS of $2.26-2.28 vs. $2.17 Capital IQ Consensus Estimate
Raises FY14 outlook to 25-26% rev growth from prior guidance of 21-23%